Details for New Drug Application (NDA): 210954
✉ Email this page to a colleague
The generic ingredient in ERYTHROMYCIN is erythromycin stearate. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin stearate profile page.
Summary for 210954
Tradename: | ERYTHROMYCIN |
Applicant: | Amneal Pharms Co |
Ingredient: | erythromycin |
Patents: | 0 |
Pharmacology for NDA: 210954
Physiological Effect | Decreased Sebaceous Gland Activity |
Medical Subject Heading (MeSH) Categories for 210954
Suppliers and Packaging for NDA: 210954
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ERYTHROMYCIN | erythromycin | TABLET, DELAYED RELEASE;ORAL | 210954 | ANDA | Amneal Pharmaceuticals NY LLC | 69238-1471 | 69238-1471-1 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (69238-1471-1) |
ERYTHROMYCIN | erythromycin | TABLET, DELAYED RELEASE;ORAL | 210954 | ANDA | Amneal Pharmaceuticals NY LLC | 69238-1471 | 69238-1471-3 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (69238-1471-3) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 250MG | ||||
Approval Date: | Jul 2, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 333MG | ||||
Approval Date: | Jul 2, 2019 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 500MG | ||||
Approval Date: | Jul 2, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription